Actigraphy, a valuable tool for objective sleep evaluation in psoriasis: a review
- PMID: 40220142
- PMCID: PMC11993492
- DOI: 10.1007/s00403-025-04187-x
Actigraphy, a valuable tool for objective sleep evaluation in psoriasis: a review
Abstract
Psoriasis, a form of chronic inflammatory skin disease, shows wide variations in severity and comorbidities. Considering the relatively clear scientific evidence concerning its great physical and psychological effects, researchers began to use actigraphy as a scientific monitoring tool for its bidirectional relationship with sleep. To evaluate the usefulness of actigraphy as a means to diagnose sleep disturbances in psoriatic patients. We performed a systematic review using PubMed, Scopus and Google Scholar to look at the use of actigraphy in research into psoriasis and sleep disorders. This review covered publications through February 2024. Included records were primary and secondary research papers. Actigraphy consistently revealed strong links between pruritus nighttime arousal, and poorer subjective sleep, although next-day psoriasis symptoms did not always worsen. Systematic analyses emphasized actigraphy's role in measuring nocturnal scratching, supported by emerging smartwatch apps. Psoriatic arthritis studies likewise reported significant sleep disruptions, though evidence remains limited. From these studies, actigraphy presented as a useful tool in both clinical and research contexts, for diagnosing and monitoring sleep disorders among psoriatic patients. Actigraphy is an important test for psoriatic sleep disorders, providing useful objective data. This way the bridge between psoriasis and sleep be clearly understood, and treatment methods improved.
Keywords: Actigraphy; Dermatology; Patient management; Psoriasis; Sleep disorders.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Consent for participation: The authors obtained written consent from patients for their photographs and medical information to be published in print and online and with the understanding that this information may be publicly available. Patient consent forms were not provided to the journal but are retained by the authors. Competing interests: The authors declare no competing interests.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated.
-
Pharmacotherapies for sleep disturbances in Alzheimer's disease.Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178. doi: 10.1002/14651858.CD009178.pub3. PMID: 24659320 Updated.
References
-
- Michalek Im, Loring B, John S (2017) m. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 31(2):205–212. 10.1111/jdv.13854 - PubMed
-
- De Arruda LHF, De Moraes APF (2001) The impact of psoriasis on quality of life. Br J Dermatol 144(s58):33–36. 10.1046/j.1365-2133.2001.144s58033.x - PubMed
-
- Jensen P, Zachariae C, Skov L, Zachariae R (2018) Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol 179(6):1376–1384. 10.1111/bjd.16702 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical